Prime Medicine (PRME) Other Non-Current Liabilities (2024 - 2026)
Prime Medicine (PRME) posted Other Non-Current Liabilities of $18.0 million for Q1 2026, little changed on a QoQ basis from $18.0 million in Q4 2025, and up 50.0% year-over-year from $12.0 million in Q1 2025.
Prime Medicine (PRME) Other Non-Current Liabilities (2024 - 2026) Analysis & Trends
Prime Medicine's Other Non-Current Liabilities history runs 3 years deep, the most recent figure standing at $18.0 million for Q1 2026.
- Quarterly Other Non-Current Liabilities rose 50.0% year-over-year to $18.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $18.0 million (up 50.0% YoY) and the FY2025 annual result came in at $18.0 million, up 200.0% from the prior year.
- Other Non-Current Liabilities was $18.0 million for Q1 2026 at Prime Medicine, roughly flat from $18.0 million in the prior quarter.
- Across five years, Other Non-Current Liabilities topped out at $18.0 million in Q3 2025 and bottomed at $6.0 million in Q1 2024.
- A 3-year average of $11.3 million and a median of $12.0 million in 2025 frame the typical range for Other Non-Current Liabilities.
- Annual changes were most pronounced in 2025 — Other Non-Current Liabilities surged 200.0% — and 2026, when it jumped 50.0%.
- Prime Medicine's Other Non-Current Liabilities stood at $6.0 million in 2024, then jumped by 200.0% to $18.0 million in 2025, then changed by 0.0% to $18.0 million in 2026.
- Business Quant data shows PRME's Other Non-Current Liabilities at $18.0 million in Q1 2026, $18.0 million in Q4 2025, and $18.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Prime Medicine | 525.98 Mn | 525.98 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 18.00 Mn |
| Dec 31, 2025 | 18.00 Mn |
| Sep 30, 2025 | 18.00 Mn |
| Jun 30, 2025 | 12.00 Mn |
| Mar 31, 2025 | 12.00 Mn |
| Dec 31, 2024 | 6.00 Mn |
| Sep 30, 2024 | 6.00 Mn |
| Jun 30, 2024 | 6.00 Mn |
| Mar 31, 2024 | 6.00 Mn |